CARLEE COX: Open Payments
NPI 1639762990 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,719 in 97 payments from 29 companies in 2025. Trend: 2023 $1,055 · 2024 $1,209 · 2025 $1,719
Food & beverage: $1,719
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $247 |
| Corcept Therapeutics | 12 | $203 |
| Amgen Inc. | 13 | $148 |
| Lilly USA, LLC | 11 | $145 |
| CeQur Corporation | 1 | $133 |
| RECORDATI_RARE_DISEASES_INC. | 5 | $100 |
| Tandem Diabetes Care, Inc. | 6 | $81 |
| Madrigal Pharmaceuticals | 2 | $74 |
| Regeneron Healthcare Solutions, Inc. | 2 | $69 |
| BETA BIONICS, INC. | 4 | $62 |
Products named: Korlym, Ozempic, CeQur Simplicity, MOUNJARO, ISTURISA, DUPIXENT, REPATHA, Wegovy.
Industry payments across IN — which companies pay providers there.
